Asterias Biotherapeutics, Inc. (AST) is a publicly traded company in the Unknown sector. Across all available filings, 15 corporate insiders have executed 94 transactions totaling $1.6M, demonstrating a bullish sentiment with $916.9K in net insider flow. The most recent transaction on Mar 1, 2019 involved a transaction of 44,471 shares valued at $42.2K.
No significant insider buying has been recorded for AST in the recent period.
No significant insider selling has been recorded for AST in the recent period.
Based on recent SEC filings, insider sentiment for AST is bullish with an Insider Alignment Score of 79/100 and a net flow of $916.9K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Asterias Biotherapeutics, Inc. (AST) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 15 insiders are actively trading AST stock, having executed 94 transactions in the past 90 days. The most active insider is Capital Inc Broadwood (Executive), who has made 4 transactions totaling $2.5M.
Get notified when executives and directors at AST file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Mar 1, 2019 | Daniel Chavez Ryan | Executive | Payment | 44,471 | $0.95 | $42.2K | |
| Mar 1, 2019 | Daniel Chavez Ryan | Executive | Award | 145,263 | $N/A | $0 | |
| Mar 1, 2019 | H. Mulroy Michael | Executive | Award | 252,606 | $N/A | $0 | |
| Mar 1, 2019 | H. Mulroy Michael | Executive | Payment | 76,588 | $0.95 | $72.8K | |
| Mar 1, 2019 | Wirth Edward | Executive | Payment | 48,826 | $0.95 | $46.4K | |
| Mar 1, 2019 | Wirth Edward | Executive | Award | 156,452 | $N/A | $0 | |
| Jan 2, 2019 | Wirth Edward | Executive | Payment | 20,440 | $0.68 | $13.9K | |
| Jan 2, 2019 | Daniel Chavez Ryan | Executive | Payment | 20,440 | $0.68 | $13.9K | |
| Aug 27, 2018 | H. Mulroy Michael | Executive | Purchase | 3,141 | $1.59 | $5.0K | |
| Jul 25, 2018 | H. Mulroy Michael | Executive | Purchase | 2,950 | $1.69 | $5.0K | |
| Jun 25, 2018 | H. Mulroy Michael | Executive | Purchase | 3,067 | $1.63 | $5.0K | |
| May 25, 2018 | H. Mulroy Michael | Executive | Purchase | 3,153 | $1.59 | $5.0K | |
| Apr 25, 2018 | H. Mulroy Michael | Executive | Purchase | 3,752 | $1.33 | $5.0K | |
| Mar 30, 2018 | Daniel Chavez Ryan | Executive | Payment | 6,483 | $1.45 | $9.4K | |
| Mar 30, 2018 | Wirth Edward | Executive | Payment | 6,483 | $1.45 | $9.4K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Other(J) | 3 | $2.5M | 36.3% |
Exercise (Options)(X) | 2 | $2.3M | 34.0% |
Purchase(P) | 26 | $1.2M | 18.0% |
Payment(F) | 22 | $452.9K | 6.6% |
Sale(S) | 16 | $324.2K | 4.7% |
Exercise(M) | 5 | $29.3K | 0.4% |
Award(A) | 20 | $0 | 0.0% |
Insiders at Asterias Biotherapeutics, Inc. are accumulating shares at an accelerated pace. With 15 insiders making 94 transactions totaling $1.2M in purchases versus $324.2K in sales, the net buying activity of $916.9K signals strong executive confidence. Capital Inc Broadwood (Executive) leads the buying activity with $2.5M in transactions across all time.